-
1
-
-
58149145611
-
Spironolactone suppresses inflammation and prevents l-NAME-induced renal injury in rats
-
Ikeda H, Tsuruya K, Toyonaga J et al. Spironolactone suppresses inflammation and prevents l-NAME-induced renal injury in rats. Kidney Int 2009; 75: 147-155.
-
(2009)
Kidney Int
, vol.75
, pp. 147-155
-
-
Ikeda, H.1
Tsuruya, K.2
Toyonaga, J.3
-
2
-
-
0035089816
-
The role of nitric oxide and the renin-angiotensin system in salt-restricted Dahl rats
-
Kataoka H, Otsuka F, Ogura T et al. The role of nitric oxide and the renin-angiotensin system in salt-restricted Dahl rats. Am J Hypertens 2001; 14: 276-285.
-
(2001)
Am J Hypertens
, vol.14
, pp. 276-285
-
-
Kataoka, H.1
Otsuka, F.2
Ogura, T.3
-
3
-
-
33745711905
-
Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats
-
Pechanova O, Matuskova J, Capikova D et al. Effect of spironolactone and captopril on nitric oxide and S-nitrosothiol formation in kidney of L-NAME-treated rats. Kidney Int 2006; 70: 170-176.
-
(2006)
Kidney Int
, vol.70
, pp. 170-176
-
-
Pechanova, O.1
Matuskova, J.2
Capikova, D.3
-
4
-
-
33744981628
-
Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker
-
Nagase M, Shibata S, Yoshida S et al. Podocyte injury underlies the glomerulopathy of Dahl salt-hypertensive rats and is reversed by aldosterone blocker. Hypertension 2006; 47: 1084-1093.
-
(2006)
Hypertension
, vol.47
, pp. 1084-1093
-
-
Nagase, M.1
Shibata, S.2
Yoshida, S.3
-
5
-
-
0031765012
-
Nitric oxide inhibits aldosterone synthesis by a guanylyl cyclase-independent effect
-
Hanke CJ, Drewett JG, Myers CR et al. Nitric oxide inhibits aldosterone synthesis by a guanylyl cyclase-independent effect. Endocrinology 1998; 139: 4053-4060.
-
(1998)
Endocrinology
, vol.139
, pp. 4053-4060
-
-
Hanke, C.J.1
Drewett, J.G.2
Myers, C.R.3
-
6
-
-
0033587515
-
Nitric oxide inhibits human aldosteronogenesis without guanylyl cyclase stimulation
-
Kreklau EL, Carlson EJ, Drewett JG. Nitric oxide inhibits human aldosteronogenesis without guanylyl cyclase stimulation. Mol Cell Endocrinol 1999; 153: 103-111.
-
(1999)
Mol Cell Endocrinol
, vol.153
, pp. 103-111
-
-
Kreklau, E.L.1
Carlson, E.J.2
Drewett, J.G.3
-
7
-
-
6044274619
-
Chronic administration of nitric oxide reduces angiotensin II receptor type 1 expression and aldosterone synthesis in zona glomerulosa cells
-
Nithipatikom K, Holmes BB, McCoy MJ et al. Chronic administration of nitric oxide reduces angiotensin II receptor type 1 expression and aldosterone synthesis in zona glomerulosa cells. Am J Physiol Endocrinol Metab 2004; 287: E820-E827.
-
(2004)
Am J Physiol Endocrinol Metab
, vol.287
-
-
Nithipatikom, K.1
Holmes, B.B.2
McCoy, M.J.3
-
8
-
-
13244259473
-
Measurement of steroid synthesis in zona glomerulosa cells by liquid chromatography-electro-spray ionization-mass spectrometry: Inhibition by nitric oxide
-
Nithipatikom K, Holmes BB, Isbell MA et al. Measurement of steroid synthesis in zona glomerulosa cells by liquid chromatography-electro-spray ionization-mass spectrometry: inhibition by nitric oxide. Anal Biochem 2005; 337: 203-210.
-
(2005)
Anal Biochem
, vol.337
, pp. 203-210
-
-
Nithipatikom, K.1
Holmes, B.B.2
Isbell, M.A.3
-
9
-
-
0015610060
-
The roles of plasma binding and receptor specificity in the mineralocorticoid action of aldosterone
-
Funder JW, Feldman D, Edelman IS. The roles of plasma binding and receptor specificity in the mineralocorticoid action of aldosterone. Endocrinology 1973; 92: 994-1004.
-
(1973)
Endocrinology
, vol.92
, pp. 994-1004
-
-
Funder, J.W.1
Feldman, D.2
Edelman, I.S.3
-
10
-
-
84930304444
-
Infusion of aldosterone, 9-alpha-fluorohydrocortisone, and antidiuretic hormone into the renal artery of normal and adrenalectomized unanesthetized dogs: Effect on electrolyte and water excretion
-
Barger AC, Berlin RD, Tulenko JF. Infusion of aldosterone, 9-alpha-fluorohydrocortisone, and antidiuretic hormone into the renal artery of normal and adrenalectomized unanesthetized dogs: effect on electrolyte and water excretion. Endocrinology 1958; 62: 804-815.
-
(1958)
Endocrinology
, vol.62
, pp. 804-815
-
-
Barger, A.C.1
Berlin, R.D.2
Tulenko, J.F.3
-
11
-
-
57249096324
-
The effect of cortisone, hydrocortisone, and 9-alpha-fluoro-16-alpha-hydroxy-delta-hydrocortisone on the action of desoxycorticosterone and aldosterone with respect to electrolyte excretion
-
Uete T, Venning EH. The effect of cortisone, hydrocortisone, and 9-alpha-fluoro-16-alpha-hydroxy-delta-hydrocortisone on the action of desoxycorticosterone and aldosterone with respect to electrolyte excretion. Endocrinology 1960; 67: 62-69.
-
(1960)
Endocrinology
, vol.67
, pp. 62-69
-
-
Uete, T.1
Venning, E.H.2
-
12
-
-
0014898867
-
I dentification of four types of steroid by their interaction with mineralocorticoid receptors in the toad bladder
-
Alberti KGMM, Sharp GWG. I dentification of four types of steroid by their interaction with mineralocorticoid receptors in the toad bladder. J Endocrinology 1970; 48: 563-574.
-
(1970)
J Endocrinology
, vol.48
, pp. 563-574
-
-
Alberti, K.G.M.M.1
Sharp, G.W.G.2
-
13
-
-
0026354008
-
11-Dehydrocorticosterone, a glucocorticoid metabolite, inhibits aldosterone action in toad bladder
-
Brem AS, Matheson KL, Barnes JL et al. 11-Dehydrocorticosterone, a glucocorticoid metabolite, inhibits aldosterone action in toad bladder. Am J Physiol 1991; 261: F873-F879.
-
(1991)
Am J Physiol
, vol.261
-
-
Brem, A.S.1
Matheson, K.L.2
Barnes, J.L.3
-
14
-
-
0021217076
-
Glucocorticoid inhibition of mineralocorticoid action in the rat
-
Kenyon CJ, Saccoccio NA, Morris DJ. Glucocorticoid inhibition of mineralocorticoid action in the rat. Clin Sci (Lond) 1984; 67: 329-335.
-
(1984)
Clin Sci (Lond)
, vol.67
, pp. 329-335
-
-
Kenyon, C.J.1
Saccoccio, N.A.2
Morris, D.J.3
-
15
-
-
0034126395
-
Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues
-
Morris DJ, Souness GW, Brem AS et al. Interactions of mineralocorticoids and glucocorticoids in epithelial target tissues. Kidney Int 2000; 57: 1370-1373.
-
(2000)
Kidney Int
, vol.57
, pp. 1370-1373
-
-
Morris, D.J.1
Souness, G.W.2
Brem, A.S.3
-
16
-
-
0035958952
-
The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2
-
Odermatt A, Arnold P, Frey FJ. The intracellular localization of the mineralocorticoid receptor is regulated by 11beta-hydroxysteroid dehydrogenase type 2. J Biol Chem 2001; 276: 28484-28492.
-
(2001)
J Biol Chem
, vol.276
, pp. 28484-28492
-
-
Odermatt, A.1
Arnold, P.2
Frey, F.J.3
-
17
-
-
0035687851
-
Mineralocorticoids and cardiac fibrosis: The decade in review
-
Funder J. Mineralocorticoids and cardiac fibrosis: the decade in review. Clin Exp Pharmacol Physiol 2001; 28: 1002-1006.
-
(2001)
Clin Exp Pharmacol Physiol
, vol.28
, pp. 1002-1006
-
-
Funder, J.1
-
18
-
-
49649085000
-
The aggravating mechanisms of aldosterone on kidney fibrosis
-
1459-1 462
-
Remuzzi G, Cattaneo D, Perico N. The aggravating mechanisms of aldosterone on kidney fibrosis. J Am Soc Nephrol 2008; 19: 1459-1 462.
-
(2008)
J Am Soc Nephrol
, vol.19
-
-
Remuzzi, G.1
Cattaneo, D.2
Perico, N.3
|